Css LLC Ionis Pharmaceuticals Inc Call Options Transaction History

Css LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $531,540 - $649,350	9,000 Added 150.0%	15,000 $899,000
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $74,508 - $103,368	-1,200 Reduced 16.67%	6,000 $386,000
Q1 2019 May 15, 2019	SELL	$52.92 - $81.17 $111,132 - $170,457	-2,100 Reduced 22.58%	7,200 $585,000
Q4 2018 Feb 14, 2019	BUY	$43.37 - $59.54 $52,044 - $71,448	1,200 Added 14.81%	9,300 $503,000
Q3 2018 Nov 14, 2018	BUY	$42.88 - $53.7 $4,288 - $5,370	100 Added 1.25%	8,100 $418,000
Q1 2018 May 15, 2018	SELL	$44.08 - $55.05 $617,120 - $770,700	-14,000 Reduced 63.64%	8,000 $352,000
Q4 2017 Feb 14, 2018	BUY	$50.3 - $64.39 $503,000 - $643,900	10,000 Added 83.33%	22,000 $1.11 Million
Q3 2017 Nov 14, 2017	BUY	$45.56 - $59.57 $546,720 - $714,840	12,000	12,000 $608,000

394

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.99B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.